Sphingosomes: A Novel Vesicular Drug Delivery System
Maimuna Fatima, C. V. Sai Sravani, K. Latha, M. Sujatha · European journal of parenteral & pharmaceutical sciences · 2026
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
European journal of parenteral & pharmaceutical sciences · OpenAlex · article · 2026
Abstract
This novel drug delivery system strives to sustain drug effect at a pre-determined rate or keep up a relatively constant and effective drug amount within the body, along with concomitant reduction in undesirable side effects. Vesicular systems consist of highly ordered assemblies of one or several concentric lipid-bilayers. By enclosing an active medication inside the vesicular structures such as niosomes, liposomes, ethosomes, and pharmacosomes, a transferosomes enhanced therapeutic index can be acquired for both new and existing drug molecules. Sphingosomes are one such system in which aqueous volume is thoroughly bound to a sphingolipid-bilayer membrane.
Sphingosomes resolve the vital downsides of vesicle systems (niosomes, liposomes) such as low stability, poor tumour stocking potency in cancer treatment and less in-vivo circulation time. The present overview indicates that this vesicular system represents a propitious system of drug delivery to supply curative compounds for a vast span of feasible applications. Keywords: Sphingosomes, Cholesterol, Vesicular systems, Sphingolipids, Lipid-bilayers, Niosomes, Liposomes.
Open the resolved locator · 10.37521/ejpps31207
Metadata licence: OpenAlex metadata (CC0)